Weigao Orthopedics Redirects R&D Funds to Acquire 55% Stake in Jiesibai'er for RMB 86.46 Million Amid Target's Near RMB 30 Million Liabilities

December 11,WEGO ORTHO(688161) announced that the company plans to change 86.46 million yuan of unused raised funds from the "R&D Center Construction Project" to acquire part of the equity of Suzhou Jiesbyer Medical Technology Co., Ltd. and increase its capital.

After the completion of the transaction, the company will hold 55% of Jiesbyer Medical's equity and include it in the consolidated financial statements. The proportion of this change in funds to the net amount of raised funds is 6.25%. In addition, the original planned investment for the "R&D Center Construction Project" was 380 million yuan, and the remaining raised funds will continue to be used for the construction of this project.

Jiesbyer Medical's main products include spinal endoscopes and orthopedic joint endoscopes, demonstrating strong R&D capabilities.

According to the announcement, as of September 30, 2025, Jiesbyer Medical's total assets amounted to 19.85 million yuan, with total liabilities at 27.23 million yuan and a net profit of -4.35 million yuan, indicating its relatively small operating scale and ongoing investment in R&D.

In the first three quarters of 2025, WEGO ORTHO achieved revenue of 1.106 billion yuan and a net profit attributable to parent company of 207 million yuan.